Cardiovascular Protection Tracks With Wine Intake, Now Provable With Urinary Marker Biomarker of wine consumption believed to reduce misclassification and bias in study Dec 18, 2024
Recalled Pacemakers; FDA Rejects Full Andexxa Approval; Ticagrelor Back in Hot Seat Recent developments of interest in cardiovascular medicine Dec 17, 2024
Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk Patients Signal largely driven by newly emerging arrhythmias Dec 12, 2024
HEARTS Act Gets Senate Vote; New Myocarditis Classes; Aftermath of PAD Device Scare Recent developments of interest in cardiovascular medicine Dec 10, 2024
Arrhythmia Risk of Lamotrigine Questioned by Observational Data Two cohort studies didn't find significantly greater risk than other drugs in epilepsy Dec 10, 2024
GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots 20% lower risk of VTE observed in large retrospective study of diabetes patients Dec 08, 2024
Women's CVD Risk Calculations Barely Budge When Sex-Specific Variables Are Included Existing models improved only slightly after accounting for certain female risk factors Dec 06, 2024
Asylum Seekers Enter U.S. With Unexpectedly Large Symptom Load Stress, CVD, pain symptoms highly prevalent in those evaluated in New York City Dec 05, 2024
Daily Chores May Provide Cardiovascular Protection in Women Who Don't Exercise Short bouts of vigorous intermittent lifestyle physical activity tied to lower risk of MACE Dec 03, 2024
Timelier U.S. Guidelines; Spouse's Personality & CVD; 'Hostile' Cardiologists Out Recent developments of interest in cardiovascular medicine Dec 03, 2024
ASCVD Mortality Linked to Specific Air Pollution Sources Pollution-mortality relationship evidenced at the level of PM2.5 source type Nov 27, 2024
Brain Volume Changes Come 10 Years Sooner for Men With Cardiovascular Risks Men faced neurodegeneration a decade earlier than women Nov 26, 2024
Hunting & Heart Attacks; Cardiologist's Whistleblower Suit; Algorithm Predicts Death Recent developments of interest in cardiovascular medicine Nov 26, 2024
Acoramidis Snags FDA Approval for ATTR Cardiomyopathy Another pricey TTR stabilizer to hit shelves Nov 25, 2024
Medications to Reduce Lipoprotein(a); Genome Models and CVD Risk Also in TTHealthWatch: genetic testing of couples planning pregnancy Nov 23, 2024 podcast
Metformin, Lifestyle Changes Fail to Reduce Afib Burden Standard of care prevails in single-center trial Nov 20, 2024
Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapy Benefit shown in trial of patients flagged for high risk of cardiotoxicity Nov 20, 2024
More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years Recent developments of interest in cardiovascular medicine Nov 19, 2024
Nasal Spray Diuretic Shows Potential for Heart Failure in Trial of Healthy Adults Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts Nov 19, 2024
Reused Pacemakers Good as New in Early Safety Data No excess infections when pacemakers were cleaned and repackaged for resource-deprived patients Nov 18, 2024
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy Most are eligible for weight management indication Nov 18, 2024
Study: Statins Mitigate Heart Risks From JAK Inhibitors Is this the final finding from ORAL Surveillance? Don't count on it. Nov 18, 2024
Left Atrial Appendage Closure Reduced Bleeding After Afib Ablation Procedure also noninferior to anticoagulation for death, stroke, or systemic embolism composite Nov 18, 2024
Spironolactone Misses the Mark in Acute MI Without HF Drug discontinuations may have leveled any benefit in CLEAR OASIS 9 trial Nov 17, 2024
Is DOAC a Viable Option After Bioprosthetic Valve Surgery Even in Sinus Rhythm? Japanese trial supports use but event risk might be low enough to suggest a different strategy Nov 17, 2024
Big Blow to Anticoagulation Strategy Against Afib-Related Cognition Problems Microemboli now questioned as driver of cognitive impairment in atrial fibrillation Nov 17, 2024
Novel CRISPR-Cas9-Based Promising in ATTR Cardiomyopathy One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial Nov 17, 2024
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
Larger Study Supports Safety of Tetracyclines During Early Pregnancy Jury is still out, however, without more rigorous evidence Nov 14, 2024
New Rescuer Guidelines Tackle Rise of Drowning Deaths in U.S. American Heart Association, American Academy of Pediatrics stress CPR with breaths, compressions Nov 12, 2024
Post-Pandemic OHCA Survival Down; Vitamin D Supplements & BP; Varipulse PFA Approved Recent developments of interest in cardiovascular medicine Nov 12, 2024
Who Needs a Defibrillator After MI? FDA Recs on Inferior Vena Cava Filters Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes Nov 09, 2024 podcast
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
Simple Measures Ease Cardiac Strain in 100-Degree Weather But electric fans were associated with harm in a hot and dry setting Nov 07, 2024
Tricuspid Valve Replacement Finds Surer Footing With TRISCEND II's 1-Year Report Evoque device helped outcomes in severe tricuspid regurgitation, with some safety caveats Oct 31, 2024
Colchicine Goes Belly-Up in a More Definitive Heart Attack Trial Larger CLEAR OASIS 9 trial could not replicate past results Oct 30, 2024
Cold Weather Heart Attacks; Preemptive Valve Procedures Flop; Better Bleeding Score Recent developments of interest in cardiovascular medicine Oct 29, 2024
SGLT2 Inhibitor Carry-Over Benefits Last How Long? Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart Oct 29, 2024
